Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Roman

Showing results (151-160 of 165) with videos related to

Pageof 17
Sort By:
Endocrine|December 6, 2017
Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features category?Bin Xu, Nada Farhat, Justine A Barletta, et al.
Head & Neck|July 12, 2019
Timing of surgery and adjuvant radiation therapy for sinonasal malignancies: Effect of surgical approachRoy Xiao, Rohan R Joshi, Qasim Husain, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 17, 2018
Tumor Board Conferences for Multidisciplinary Skin Cancer Management: A Survey of US Cancer CentersShoko Mori, Cristian Navarrete-Dechent, Tatyana A Petukhova, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 23, 1999
Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPID W Snyder, N J Bach, R D Dillard, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studiesW T Jackson, L L Froelich, R J Boyd, et al.
JAMA Oncology|May 26, 2017
Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation TechniquesJonathan E Leeman, Jin-Gao Li, Xin Pei, et al.
Cell Reports|June 30, 2021
Breast tumor stiffness instructs bone metastasis via maintenance of mechanical conditioningAdam W Watson, Adam D Grant, Sara S Parker, et al.
Thyroid : Official Journal of the American Thyroid Association|February 26, 2024
<i>RAS</i>-Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active SurveillanceHannah J Sfreddo, Elizabeth S Koh, Karena Zhao, et al.
Science (New York, N.Y.)|January 6, 2018
Declining oxygen in the global ocean and coastal watersDenise Breitburg, Lisa A Levin, Andreas Oschlies, et al.
Oral Oncology|March 18, 2020
Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancersDan Fan, Jung J Kang, Ming Fan, et al.
Pageof 17

Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
Endocrine|December 6, 2017
Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features category?Bin Xu, Nada Farhat, Justine A Barletta, et al.
Head & Neck|July 12, 2019
Timing of surgery and adjuvant radiation therapy for sinonasal malignancies: Effect of surgical approachRoy Xiao, Rohan R Joshi, Qasim Husain, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 17, 2018
Tumor Board Conferences for Multidisciplinary Skin Cancer Management: A Survey of US Cancer CentersShoko Mori, Cristian Navarrete-Dechent, Tatyana A Petukhova, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 23, 1999
Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPID W Snyder, N J Bach, R D Dillard, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studiesW T Jackson, L L Froelich, R J Boyd, et al.
JAMA Oncology|May 26, 2017
Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation TechniquesJonathan E Leeman, Jin-Gao Li, Xin Pei, et al.
Cell Reports|June 30, 2021
Breast tumor stiffness instructs bone metastasis via maintenance of mechanical conditioningAdam W Watson, Adam D Grant, Sara S Parker, et al.
Thyroid : Official Journal of the American Thyroid Association|February 26, 2024
<i>RAS</i>-Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active SurveillanceHannah J Sfreddo, Elizabeth S Koh, Karena Zhao, et al.
Science (New York, N.Y.)|January 6, 2018
Declining oxygen in the global ocean and coastal watersDenise Breitburg, Lisa A Levin, Andreas Oschlies, et al.
Oral Oncology|March 18, 2020
Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancersDan Fan, Jung J Kang, Ming Fan, et al.
Pageof 17